Xeris Biopharma Holdings XERS

Health care sectorNasdaq

Company

Exchange: Nasdaq
Sector: Health care
Industry: Pharmaceutical Preparations
Headquarters: Chicago, Illinois
Fiscal year end: 12/31
Next earnings: 10/11, estimated

No member of Congress reported a trade in Xeris Biopharma Holdings XERS in the past 90 days. Insiders filed 0 purchases and 1 sale on the open market over the same period, a net sale of $250K.

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: No record; Last 90 days · 0 buys · 0 sales
Insider net buying: −$250K; Last 90 days · bought $0 · sold $250K
Next earnings: 10/11; Estimated from the last four quarters

26-week trading

Common questions

Did Xeris Biopharma Holdings XERS insiders buy or sell in the past 90 days?: In the past 90 days insiders filed 0 purchases and 1 sale on the open market. Sales came to $250K.